BioLattice Ophthalmics, Inc.
April 06, 2024
Session
Company Description: We are addressing the need for tissue repair solutions, beginning with cornea. One in 70 patients who need cornea tissue obtain it. Globally 2 million per year suffer from corneal blindness while only 200,000 per year receive vision restoration via cornea transplant. There is no standard of care alternative to donor cornea tissue for full thickness cornea transplant material. Our engineered cornea will be a true alternative to donor cornea.
